SK

Sujata Khanna

Active Director Director DIN 01505643
DIN 01505643 First appointment May 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2007
Shareholding value •••• Premium profile

About Sujata Khanna

Data last updated:

Sujata Khanna is a Director at Times Drugs And Pharmaceticals Private Limited (since 2007). The company operates in Pharma. Times Drugs And Pharmaceticals Private Limited reported revenue of ₹2.29 Cr (FY 2025).

DIN 01505643
Primary Designation Director
Industry Pharma
First Appointment 10 May 2007
Oldest Company Age 29 yrs
Largest company Times Drugs And Pharmaceticals Private Limited · ₹2.29 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20071997₹2.29 Cr (FY 2025)Active

Board colleagues of Sujata Khanna

Directorship timeline

Open interactive timeline →
Times Drugs And Pharmaceticals Private Limited
Premium access

Shareholding and investment profile for Sujata Khanna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sujata Khanna

Sujata Khanna currently holds 1 directorship: Times Drugs And Pharmaceticals Private Limited (Director, since 10 May 2007, revenue ₹2.29 Cr (FY 2025)).

Sujata Khanna was first appointed on 10 May 2007 as Director at Times Drugs And Pharmaceticals Private Limited.

The current boards of Sujata Khanna's companies include Vijay Khanna Kumar (Times Drugs And Pharmaceticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available